Home  >  Products  >  VTI1B (vesicle transport through interaction with t-SNAREs homolog 1B (yeast) ) Blocking Peptide (the C terminal of VTI1B)(100ug)
VTI1B (vesicle transport through interaction with t-SNAREs homolog 1B (yeast) ) Blocking Peptide (the C terminal of VTI1B)(100ug)

VTI1B (vesicle transport through interaction with t-SNAREs homolog 1B (yeast) ) Blocking Peptide (the C terminal of VTI1B)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-VTI1B Antibody (ARP61763_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61763
Size: 100ug
Weight: 26kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: V-SNARE that mediates vesicle transport pathways through interactions with t-SNAREs on the target membrane. These interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers. It may be concerned with increased secretion of cytokines associated with cellular senescence.
Alternative names: VTI1; VTI1-LIKE; VTI1L; VTI2
See Full Product Listings >